These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15494840)

  • 41. Rationale of azithromycin prescribing practices for enteric fever in India.
    Rai S; Jain S; Prasad KN; Ghoshal U; Dhole TN
    Indian J Med Microbiol; 2012; 30(1):30-3. PubMed ID: 22361757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal.
    Acharya D; Trakulsomboon S; Madhup SK; Korbsrisate S
    Jpn J Infect Dis; 2012; 65(3):264-7. PubMed ID: 22627312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of antimicrobial resistance, molecular and phage types of Salmonella enterica serovar Typhi isolations.
    Demczuk WH; Finley R; Nadon C; Spencer A; Gilmour M; Ng LK; ; ;
    Epidemiol Infect; 2010 Oct; 138(10):1414-26. PubMed ID: 20149265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increasing fluoroquinolone resistance in Salmonella typhi in Ontario, 2002-2007.
    Morris SK; Richardson SE; Sauve LJ; Ford-Jones EL; Jamieson F
    Am J Trop Med Hyg; 2009 Jun; 80(6):1012-3. PubMed ID: 19478267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border.
    Lutterloh E; Likaka A; Sejvar J; Manda R; Naiene J; Monroe SS; Khaila T; Chilima B; Mallewa M; Kampondeni SD; Lowther SA; Capewell L; Date K; Townes D; Redwood Y; Schier JG; Nygren B; Tippett Barr B; Demby A; Phiri A; Lungu R; Kaphiyo J; Humphrys M; Talkington D; Joyce K; Stockman LJ; Armstrong GL; Mintz E
    Clin Infect Dis; 2012 Apr; 54(8):1100-6. PubMed ID: 22357702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis.
    Al-Khuwaitir TS; Al-Zuhair AA; Al-Ghamdi AG; Khan A
    Saudi Med J; 2008 Jan; 29(1):129-32. PubMed ID: 18176688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh.
    Saha SK; Darmstadt GL; Baqui AH; Crook DW; Islam MN; Islam M; Hossain M; El Arifeen S; Santosham M; Black RE
    J Clin Microbiol; 2006 Oct; 44(10):3811-3. PubMed ID: 17021117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA; Barrett TJ; Nelson JT; Angulo FJ
    Clin Infect Dis; 2003 Jul; 37(1):75-81. PubMed ID: 12830411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An imported enteric fever caused by a quinolone-resistant Salmonella Typhi.
    Somily AM
    Ann Saudi Med; 2010; 30(4):313-6. PubMed ID: 20622350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi.
    Ray P; Sharma J; Marak RS; Garg RK
    Indian J Med Res; 2006 Jul; 124(1):105-8. PubMed ID: 16926465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria.
    Akinyemi KO; Smith SI; Oyefolu AO; Coker AO
    Public Health; 2005 Apr; 119(4):321-7. PubMed ID: 15733694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical resistance to ciprofloxacin in Salmonella typhi.
    Rodrigues C; Mehta A; Andrews R; Joshi VR
    J Assoc Physicians India; 1998 Mar; 46(3):323-4. PubMed ID: 11273362
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.
    Crump JA; Kretsinger K; Gay K; Hoekstra RM; Vugia DJ; Hurd S; Segler SD; Megginson M; Luedeman LJ; Shiferaw B; Hanna SS; Joyce KW; Mintz ED; Angulo FJ;
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1278-84. PubMed ID: 18212096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Septic arthritis of the hip in a Cambodian child caused by multidrug-resistant Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin treated with ceftriaxone and azithromycin.
    Pocock JM; Khun PA; Moore CE; Vuthy S; Stoesser N; Parry CM
    Paediatr Int Child Health; 2014 Aug; 34(3):227-9. PubMed ID: 24749773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quinolone-resistant Salmonella enterica Serovar typhi presenting as acute fulminant hepatitis.
    Mitra S; Karthik R; Balaji V; George IA; Kapil A; Abraham OC
    J Assoc Physicians India; 2009 Apr; 57():338-9. PubMed ID: 19702041
    [No Abstract]   [Full Text] [Related]  

  • 56. Current perspectives of enteric fever: a hospital-based study from India.
    Walia M; Gaind R; Mehta R; Paul P; Aggarwal P; Kalaivani M
    Ann Trop Paediatr; 2005 Sep; 25(3):161-74. PubMed ID: 16156980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
    Ercis S; Erdem B; Hasçelik G; Gür D
    Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia.
    Yanagi D; de Vries GC; Rahardjo D; Alimsardjono L; Wasito EB; De I; Kinoshita S; Hayashi Y; Hotta H; Osawa R; Kawabata M; Shirakawa T
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):422-6. PubMed ID: 19631095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan.
    Hirose K; Tamura K; Sagara H; Watanabe H
    Antimicrob Agents Chemother; 2001 Mar; 45(3):956-8. PubMed ID: 11181390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.